Everads specializes in developing suprachoroidal delivery technology for ocular gene therapy, as self-described in various announcements regarding their innovations and clinical trials.

Everads

Everads Therapy Ltd | 290 followers on LinkedIn. Optimizing Treatment of Retinal Disease by Leveraging Novel Delivery Technology | Everads Therapy is an early-stage life sciences company developing the next generation of retinal treatment delivery technologies. With the goal of overcoming significant challenges in current treatment methodologies for retinal and macular diseases, Everads&#39; delivery system offers the promise of improving the efficacy and safety of existing and potential drug therapies. Established in 2017, Everads Therapy operates within the RAD Biomed incubator in Tel Aviv, Israel.

Hagay Drori

Executive Chairman at Everads Therapy and CEO at Moebius Medical Ltd.

Moshe Weinstein

Drug delivery design expert | Medical devices entrepreneur

Lior Raday

Clinical Operations Expert

Adi Bigger Hoggeg

Everads Therapy Ltd

💫 Everads is excited to announce that it was selected as the top startup at the Eye and Beyond II conference hosted by the Ophthalmology Division of the Rabin Medical Center. Congratulations to Keren Mano-Tamir (M.D / MBA) for this great achievement! 👏 #ophthalmology #suprachoroidal #drugdelivery #genetherapy #everads

Everads is excited to have initial clinical data using our suprachoroidal delivery technology presented at EURETINA. Congratulations to Dr. Y Barak, Head of Retina and Rambam Medical Center, for this achievement! #opthalmology #suprachoroidal #drugdelivery #genetherapy https://lnkd.in/dDdGz7E8

I am excited to share that Everads will be leading the Suprachoroidal Delivery Workshop at the gene therapy for ophthalmic disorders summit. See you there!

Everads is happy to share that the ability of our suprachoroidal delivery technology to delivery AAV-based gene therapy to the back of the eye is being presented today by Dr. Yoreh Barak of Rambam Medical Center at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting. For those at ARVO, please come by poster B0029 3:30-5:15pm! #opthalmology #suprachoroidal #drugdelivery #genetherapy

Our CEO Moshe Weinstein will be sharing updates regarding Everads and our suprachoroidal delivery platform this week at 2nd Next Generation Ophthalmic Drug Delivery conference. We look forward to seeing you there!

Viewport Meta

IPhone / Mobile Compatible

Euro

Apple Mobile Web Clips Icon

HSTS

Content Delivery Network

Google Cloud

PostalAddress Schema

Google Cloud CDN

Head of Clinical Operations

Adi Hoggeg

Head of QA/RA

Alla Iserlis

David Daily

Co-Founder & R&D Director

Tel Aviv Companies

Middle East Companies With Fewer Than 100 Employees (Top 10K)

Pharmaceutical Companies With Fewer Than 1000 Employees (Top 10K)

Private Tel Aviv Companies

Everads Therapy is a revolutionary drug and cell delivery system developing a simple treatment approach that allows for delivery of therapies into the back of the eye addressing challenges in treatment of retinal diseases. Its platform is consists of a blunt injector for applying its access method to targeting the back of the eye.

Everads Therapy was founded in 2016 and is based in Tel Aviv, Israel.

Tel Aviv

Israel

Asia

Everads Therapy

Everads Therapy wins retina commercialization deal

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 19, 2024 9:17 PM	bbb76366
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 19, 2024 9:17 PM	3414880c
crunchbase trigger	general	Nov 19, 2024 9:17 PM	03f1d610
crunchbase profile	general	Nov 20, 2024 8:52 AM	c5c532ce
li profile	general	Nov 19, 2024 9:17 PM	4532fc35
translate crunchbase fundingrounds	general	Nov 20, 2024 9:51 AM	da7e096e
peers	general	Nov 19, 2024 9:17 PM	aea0142e
news basic	general	Nov 19, 2024 9:17 PM	8526a132
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

EVER

COM:EVERADS-THERAPY

Everads